Eton Pharmaceuticals Inc. ETON
Super Investor & Insider
1
Fondi che lo detengono
#1387
Rank consenso
1.4%
% dei portafogli
$743,806
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Polen Capital Management · Polen Capital Management | 0.01% | Buy | 30,138 | $743,806 |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Eton Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development and commercialization of treatments for rare diseases, with particular focus on pediatric endocrinology and metabolic disorders. The company maintains a growing portfolio of FDA-approved commercial products including Increlex for s…
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees44
TickerETON
Statistics
Market Cap$905.1M
Revenue (TTM)$80.0M
Net Income-$4.6M
Net Margin-5.8%
EPS—
P/E124.00
P/S9.95
P/B28.23
EV/EBITDA79.11
ROE-5.4%
Dividend Yield—
Price$33.08
Data: Twelve Data · Revenue = mcap / P/S